Adrian N. Hobden

Adrian N. Hobden

Chief Executive Officer at Cerespir, Inc.

71 year
Health Technology
Finance
Consumer Services

Profile

Dr. Adrian N.
Hobden
is a Scientific Advisor at Frantz Medical Ventures and he is the President, Chief Executive Officer & Director at Myrexis, Inc. He is on the Board of Directors at Myrexis, Inc. Dr. Hobden was previously employed as President by Myriad Genetics, Inc. He also served on the board at Glaxo Wellcome, Inc. Dr. Hobden received his undergraduate degree from the University of Cambridge, a graduate degree from the University of Cambridge, and a doctorate degree from the University of Leicester.

Adrian N. Hobden active positions

CompaniesPositionStart
Private Equity Investor -
Chief Executive Officer -
Director/Board Member -
All active positions of Adrian N. Hobden

Former positions of Adrian N. Hobden

CompaniesPositionEnd
MYREXIS, INC. Chief Executive Officer 2011-07-20
Glaxo Wellcome, Inc. Corporate Officer/Principal 1998-09-30
MYRIAD GENETICS, INC. President -
See the detail of Adrian N. Hobden's experience

Training of Adrian N. Hobden

University of Leicester Doctorate Degree
University of Cambridge Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adrian N. Hobden's experience

Connections

57

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MYREXIS, INC.

Finance

MYRIAD GENETICS, INC.

Health Technology

Private companies4

Finance

Glaxo Wellcome, Inc.

Health Technology

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Adrian N. Hobden
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW